Here are five observations:
1. North America dominates the market at present, capturing a market share of more than 70 percent.
2. An awareness of BMP products and an increase in spinal fusion procedures will spur the North American market.
3. Europe follows North America in terms of market share, and the Asia Pacific region will experience the highest market growth through 2022.
4. The rhBMP-2 market segment captured the largest market share in 2013, with its increasing popularity for use in spinal fusions.
5. The spinal fusions segment dominates the market in terms of application, with trauma following.
6. Dublin, Ireland-based Medtronic; Lyon, France-based Olympus Biotech; and South Korea-based Cellumed lead the space.
More articles on devices:
Medtronic, Exactech, RTI Surgical & more: 9 device company key notes
AxioMed president comments on outpatient cervical disc replacement study: 5 observations
North America leads global neurosurgery market — 5 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
